Name | Date modified | File size |
|
|---|---|---|---|
01.症例登録票.pdf | Aug 16, 2020 | 574 KB | |
02.患者背景(ベースライン).pdf | Aug 16, 2020 | 477 KB | |
03.維持療法期:開始時.pdf | Aug 16, 2020 | 447 KB | |
04.維持療法期:3か月時.pdf | Aug 16, 2020 | 467 KB | |
05.維持療法期:6か月時.pdf | Aug 16, 2020 | 487 KB | |
06.維持療法期:9か月時.pdf | Aug 16, 2020 | 467 KB | |
07.維持療法期:12か月時.pdf | Aug 16, 2020 | 483 KB | |
08.維持療法期:有害事象報告.pdf | Aug 16, 2020 | 838 KB | |
09.TFR期:1か月時点.pdf | Aug 16, 2020 | 430 KB | |
10.TFR期:3か月時点.pdf | Aug 16, 2020 | 431 KB | |
11.TFR期:6か月時点.pdf | Aug 16, 2020 | 430 KB | |
12.TFR期:24か月時点.pdf | Aug 16, 2020 | 431 KB | |
13.TFR期:有害事象報告.pdf | Aug 16, 2020 | 435 KB | |
14.試験治療終了(中止・完了)報告.pdf | Aug 16, 2020 | 455 KB | |
15.最終転帰(観察終了)報告.pdf | Aug 16, 2020 | 446 KB | |
16.TFR期:MR4.5喪失報告.pdf | Aug 16, 2020 | 442 KB | |
17.TFR期:MMR喪失報告.pdf | Aug 16, 2020 | 444 KB | |
18.再治療期:投与報告.pdf | Aug 16, 2020 | 424 KB | |
19.再治療期:MMR再到達報告.pdf | Aug 16, 2020 | 413 KB | |
20.再治療期:ポナチニブ有害事象報告.pdf | Aug 16, 2020 | 839 KB | |
21.重篤な有害事象報告書.pdf | Aug 16, 2020 | 492 KB |
